Gerhard Steinmann

4.4k total citations · 1 hit paper
52 papers, 2.7k citations indexed

About

Gerhard Steinmann is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Gerhard Steinmann has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Hepatology and 12 papers in Immunology. Recurrent topics in Gerhard Steinmann's work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Gerhard Steinmann is often cited by papers focused on Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Gerhard Steinmann collaborates with scholars based in Germany, United States and France. Gerhard Steinmann's co-authors include H. K. Müller-Hermelink, Hans Konrad Müller‐Hermelink, Bernard Kennès, Pierre Galanaud, J Corberand, Catherine Fournier, W. Hijmans, Gerard J. Ligthart, Gerhard Nehmiz and Yves Benhamou and has published in prestigious journals such as Science, Blood and Gastroenterology.

In The Last Decade

Gerhard Steinmann

48 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Admission criteria for immunogerontological studies in man: The senieur protocol

1984 646 citations Hans Konrad Müller‐Hermelink, Gerhard Steinmann et al. Mechanisms of Ageing and Development profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerhard Steinmann Germany	20	934	928	764	331	312	52	2.7k
Mohammad Kazemi Arababadi Iran	30	1.2k 1.3×	1.1k 1.2×	617 0.8×	528 1.6×	207 0.7×	189	3.1k
Lawrence J. Abraham Australia	29	894 1.0×	1.4k 1.5×	515 0.7×	1.1k 3.2×	258 0.8×	71	4.1k
Eckart Schott Germany	32	1.6k 1.7×	798 0.9×	1.7k 2.2×	708 2.1×	188 0.6×	69	3.6k
Tao Han China	32	959 1.0×	409 0.4×	637 0.8×	856 2.6×	279 0.9×	211	3.3k
John E. Hegarty Ireland	41	1.8k 1.9×	2.0k 2.2×	2.1k 2.8×	336 1.0×	187 0.6×	106	5.0k
Pietro Di Lucia Italy	18	481 0.5×	1.2k 1.3×	295 0.4×	338 1.0×	111 0.4×	25	2.7k
Alessandra Vitelli Italy	28	2.4k 2.5×	701 0.8×	2.1k 2.7×	597 1.8×	357 1.1×	55	4.4k
Svante Hermodsson Sweden	33	962 1.0×	1.4k 1.5×	728 1.0×	469 1.4×	204 0.7×	104	3.1k
Wolfgang Schepp Germany	29	387 0.4×	826 0.9×	220 0.3×	548 1.7×	99 0.3×	179	3.2k
Andrea D. Branch United States	35	1.9k 2.0×	216 0.2×	2.0k 2.6×	622 1.9×	327 1.0×	127	3.5k

Countries citing papers authored by Gerhard Steinmann

Since Specialization

Citations

This map shows the geographic impact of Gerhard Steinmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Steinmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Steinmann more than expected).

Fields of papers citing papers by Gerhard Steinmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Steinmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Steinmann. The network helps show where Gerhard Steinmann may publish in the future.

Co-authorship network of co-authors of Gerhard Steinmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Steinmann. A scholar is included among the top collaborators of Gerhard Steinmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Steinmann. Gerhard Steinmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steinmann, Gerhard & Roland Mertelsmann. (2018). Scientific Europe Turns Into a Fair Mode: Open Access Journals Reducing The Cost of Knowledge. 5(7). 1 indexed citations

Dieterich, Douglas T., Tarik Asselah, Dominique Guyader, et al.. (2014). SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients. Antimicrobial Agents and Chemotherapy. 58(6). 3429–3436. 9 indexed citations

Sane, Rucha, Gerhard Steinmann, Yongmei Li, et al.. (2014). Mechanisms Underlying Benign and Reversible Unconjugated Hyperbilirubinemia Observed with Faldaprevir Administration in Hepatitis C Virus Patients. Journal of Pharmacology and Experimental Therapeutics. 351(2). 403–412. 22 indexed citations

Sulkowski, Mark S., Marc Bourlière, Jean-Pierre Bronowicki, et al.. (2013). Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial. Hepatology. 57(6). 2155–2163. 60 indexed citations

Sulkowski, Mark, Tarik Asselah, Jacob Lalezari, et al.. (2013). Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial. Hepatology. 57(6). 2143–2154. 86 indexed citations

Sulkowski, Mark, Marc Bourlière, J.‐P. Bronowicki, et al.. (2011). 66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R. Journal of Hepatology. 54. S30–S30. 25 indexed citations

Manns, Michael P., Marc Bourlière, Yves Benhamou, et al.. (2010). Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection. Journal of Hepatology. 54(6). 1114–1122. 89 indexed citations

Herrmann, Eva, Stefan Zeuzem, Christoph Sarrazin, et al.. (2006). Viral Kinetics in Patients with Chronic Hepatitis C Treated with the Serine Protease Inhibitor Biln 2061. Antiviral Therapy. 11(3). 371–376. 22 indexed citations

Reiser, Markus, Holger Hinrichsen, Yves Benhamou, et al.. (2005). Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C†‡. Hepatology. 41(4). 832–835. 121 indexed citations

10.

Steinmann, Gerhard, et al.. (2005). Liposuction and extravasation injuries in ICU. British Journal of Anaesthesia. 95(3). 355–357. 13 indexed citations

11.

Hinrichsen, Holger, Yves Benhamou, Heiner Wedemeyer, et al.. (2004). Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Gastroenterology. 127(5). 1347–1355. 233 indexed citations

12.

Liénard, D., Alexander M.M. Eggermont, Heimen Schraffordt Koops, et al.. (1999). Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases. Melanoma Research. 9(5). 491–502. 112 indexed citations

13.

Wasserman, Daniel, et al.. (1998). Interferon-gamma in the prevention of severe burn-related infections. Critical Care Medicine. 26(3). 434–439. 58 indexed citations

14.

Ioannovich, J., et al.. (1996). Rationale, design and performance of a clinical trial to investigate interferon-gamma (imukin) in the prophylactic treatment of severe burns-related infections. Intensive Care Medicine. 22(S4). S468–S473. 2 indexed citations

15.

Hartwig, Matthew G. & Gerhard Steinmann. (1994). On a causal mechanism of chronic thymic involution in man. Mechanisms of Ageing and Development. 75(2). 151–156. 48 indexed citations

16.

Steinmann, Gerhard, F. Rosenkaimer, Günther R. Adolf, et al.. (1992). Low incidence of antibody formation due to long-term interferon-?2c treatment of cancer patients. Journal of Molecular Medicine. 70(2). 136–41. 7 indexed citations

17.

McMahon, James B., et al.. (1989). A rapid in vitro method for the evaluation of potential antitumor drugs requiring metabolic activation by hepatic S9 enzymes. Biochemical Pharmacology. 38(24). 4477–4483. 4 indexed citations

18.

Gaudecker, Brita von, et al.. (1986). Immunohistochemical characterization of the thymic microenvironment. Cell and Tissue Research. 244(2). 403–412. 37 indexed citations

19.

Steinmann, Gerhard & H. K. Müller-Hermelink. (1983). Darstellung der terminalen Deoxynukleotidyl-Transferase im histologischen Schnitt*. Klinische Pädiatrie. 195(3). 230–233. 1 indexed citations

20.

Steinmann, Gerhard, et al.. (1978). Effect of methods of sample taking on the cytologic diagnosis of lung tumors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(5). 425–30. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact